Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes
Titel:
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes
Auteur:
Edmonston, Daniel Mulder, Hillary Lydon, Elizabeth Chiswell, Karen Lampron, Zachary Shay, Christina Marsolo, Keith Jones, William Schuyler Butler, Javed Shah, Raj C. Chamberlain, Alanna M. Ford, Daniel E. Gordon, Howard S. Hwang, Wenke Chang, Alexander Rao, Ajaykumar Bosworth, Hayden B. Pagidipati, Neha